LustGarden Foundation for Pancreatic Cancer Research

Pancreatic Cancer Research

As the largest private funder of pancreatic cancer research, we are relentlessly focused on improving patient outcomes and we are making progress every day. Thanks to separate funding to support administrative expenses, 100 percent of every donation goes directly to research.

Navigating Pancreatic Cancer

We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.

Patient Checklist

Checklist

August 1, 2018 ladmin
As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]
Lets Win! Pancreatic Cancer

Let’s Win! Pancreatic Cancer

July 20, 2018 ladmin
LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]

Pancreatic Cancer Connections

July 7, 2018 ladmin
Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery. Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.

Lustgarten News

View All Articles

International Pancreatic Cancer Trial opens

 Researchers testing organoids use in predicting treatment outcomes

A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients based on the molecular traits of tumors. The Pancreatic Cancer Convergence Dream Team is funded by the Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer® (SU2C), SU2C Canada and Pancreatic Cancer Canada. The team will be led by Jennifer Knox, MD, the Lewitt Chair in Pancreatic Cancer Research at the Princess Margaret Cancer Centre, part of University Health Network, and professor of medicine at the University of Toronto in Canada, and Elizabeth Jaffee, MD, a professor of oncology and deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland.

Learn More

Remembering Stephen Grand

Stephen Grand: Pancreatic Cancer Fighter and Research Funder

Our hearts are broken at the news of the passing of Lustgarten ally and donor, Stephen Grand of Belvedere, CA. A passionate and insightful philanthropist, as well as a pancreatic cancer patient, Steve was in the unique position of understanding the urgency of moving the research along quickly and the need to invest in the most innovative science with the greatest opportunity to drive real progress. Tomorrow is promised to no one, but Steve’s hope was that through his philanthropy pancreatic patients like himself would someday be promised more time.

Learn More

LustgartenLIVE!

Welcome to LustgartenLIVE! a new quarterly series of webinars designed to bring you face-to-face with the best researchers investigating pancreatic cancer. Moderated by Andrew Rakeman, PhD , Vice President of Research, each webinar in the series will focus on a different aspect of the research funded through your donations. Hope is on the horizon! REGISTRATION IS NOW OPEN for Early Detection: The Path Forward.
Though pancreatic cancer is considered a rare disease, it remains the third-leading cause of cancer-related death. Because we know earlier detection plays a key factor in saving and extending lives, the Lustgarten Foundation has designated early detection as a research funding priority. In this live discussion you’ll have access to the latest information from the lead scientists behind two of the most promising advances in early detection screenings:

Learn More

Pancreatic Cancer News

View All Articles

Clinical trial helps pancreatic cancer patients

25. 3. 21 ladmin
When doctors diagnosed Brenda Scully’s husband with inoperable pancreatic cancer, she was in shock. Brenda said she tried not to show her emotions to him, staying strong, “I just called the kids and cried to them. And they were very supportive. And I just said to Vince, well, we can deal with this.” But her […]

UCLA team receives $6 million from NIH to explore new pancreatic cancer therapies

25. 3. 21 ladmin
A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer. Pancreatic cancer is the third leading cause of cancer-related mortality in the United States, accounting for more than 47,000 deaths annually. […]

The Latest Quantified Self Trend: Whole-Body MRI

24. 3. 21 ladmin
I have always been interested in learning more about my body and how to use data to improve my health. When I had the opportunity to try a whole-body MRI scan from Prenuvo, a diagnostics company focusing on the early detection of cancer and other diseases, I was intrigued by what I learned. A magnetic […]

Scientists shrink pancreatic tumors by starving their cellular “neighbors

16. 3. 21 ladmin
Newswise — Scientists at Sanford Burnham Prebys Medical Discovery Institute demonstrated for the first time that blocking “cell drinking,” or macropinocytosis, in the thick tissue surrounding a pancreatic tumor slowed tumor growth—providing more evidence that macropinocytosis is a driver of pancreatic cancer growth and is an important therapeutic target. The study was published in Cancer Discovery, a journal […]

Cancer immunotherapy approach targets common genetic alteration

15. 3. 21 ladmin
Researchers developed a prototype for a new cancer immunotherapy that uses engineered T cells to target a genetic alteration common among all cancers. The approach, which stimulates an immune response against cells that are missing one gene copy, called loss of heterozygosity (LOH), was developed by researchers at the Ludwig Center, Lustgarten Laboratory and the Bloomberg~Kimmel Institute for Cancer […]

High-Dose Radiation Offers Hope for People with Inoperable Pancreatic Cancer

11. 3. 21 ladmin
Pancreatic cancer is notoriously difficult to treat, partly because surgery is not possible or is ineffective. MSK has developed a high-dose form of radiation therapy that can give safe, effective treatment to many patients who are unable to have surgery. Pancreatic cancer has proven very difficult to treat compared with more common cancers. Despite decades of […]

Study: Lowering the activity of KRAS gene can help fight pancreatic cancer

11. 3. 21 ladmin
If clinicians could stop mutations of the KRAS gene in pancreatic cancer – which happens in more than 90 percent of pancreatic cancer cases and drastically reduces response to immunotherapy – the chances of improving treatment for this deadly form of cancer would be increased. A collaborative study by Stony Brook University scientists, published in […]

New tumor-penetrating therapy may improve outcomes in patients with pancreatic cancer

9. 3. 21 ladmin
Every 12 minutes, someone in the United States dies of pancreatic cancer, which is often diagnosed late, spreads rapidly and has a five-year survival rate at approximately 10 percent. Treatment may involve radiation, surgery and chemotherapy, though often the cancer becomes resistant to drugs. Researchers at University of California San Diego School of Medicine and […]

Mutant Gene-Targeted Immunotherapy Approach Developed

1. 3. 21 ladmin
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers. The researchers targeted their immunotherapy approach to alterations in the common cancer-related p53 tumor suppressor gene, the RAS tumor-promoting oncogene or T-cell receptor […]

Molecular imaging scientist recognized as one of the top biomedical engineers in U.S.

23. 2. 21 ladmin
UC Davis professor of biomedical engineering and hematology/oncology Julie Sutcliffe has been elected to the American Institute for Medical and Biological Engineering (AIMBE) College of FellowsJulie Sutcliffe, UC Davis professor of biomedical engineering and hematology/oncology Julie Sutcliffe, UC Davis professor of biomedical engineering and hematology/oncology Sutcliffe was elected by members of the College of Fellows […]

Join Us

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Back to Top